Research fields  

Bioethics; Science, Technology and Society (STS)

Education experience     

2009       Zhejiang University (PhD)

Work experience     

2019- now   Peking University Health Science Center

2016-2017   Stanford Center for Biomedical Ethics (Fulbright Visiting Scholar)

2013-2019   College of Humanities and Development Studies, China Agricultural University (Associate Professor, Professor)

2012-2013   Asia Research Institute, National University of Singapore (Postdoctor)

2009-2012   School of Humanities, Zhejiang University (Postdoctor)

Academic community    

[1] Science, Technology and Society Journal, Collaborating Editor (2013-2017)

[2] East Asian Science, Technology and Society: an International Journal, Advisory Board (2015- ), Book Review Editor (2012-2014)

[3] Bioethics Committee of the Chinese Society for Dialectics of Nature / Philosophy of Nature, Science and Technology, Member (2016-2018), Standing Director (2018- )

[4] Sociology of Science Committee of the Chinese Society for Sociology, Member (2015-2019)

[5] The Committee of Morality and Ethics in Science, Genetics Society of China, Member (2014- )

[6] Steering Committee of the Asia-Pacific Science, Technology and Society Network (APSTSN), Member (2010-2012)

[7] The Hinxton Group: An International Consortium on Stem Cells, Ethics & Law, Member (2010- )

Courses

[1] Frontiers in Bioethics Seminar for Postgraduates

[2] Medical Ethics for Undergraduates

[3] Public Health Ethics for Undergraduates

Academic papers     

English Papers

[1]   Margaret Sleeboom-Faulkner*, Haidan Chen and Acim Rosemann, 2018, Regulatory capacity building and the governance of clinical stem cell research in China, Science and Public Policy, 45(3), 416-427.

[2]   Haidan Chen*, 2017, Reflection on the governance of clinical stem cell research and applications in China, Regenerative Medicine, 12(6), 593–597.

[3]   Lan Lü and Haidan Chen*, 2016, Chinese Public’s Risk Perceptions of Genetically Modified Food: From the 1990s to 2015. Science, Technology, and Society. 21(1), 110-128.

[4]   Haidan Chen*, 2016, Book Review People’s Science: Bodies and Rights on the Stem Cell Frontier, New Genetics and Society, 35(1), 97-99.

[5]   Haidan Chen*, Benny Chan, and Yann Joly, 2015, Privacy and Biobanking in China: A Case of Policy in Transition. Journal of Law, Medicine & Ethics. 43(4), 726-742.

[6]   Haidan Chen* and Tikki Pang, 2015, Human Genomics in Asia. In: James D. Wright (editor-in-chief), International Encyclopedia of the Social & Behavioral Sciences, 2nd edition, Vol 11. Oxford: Elsevier, pp. 318–322.

[7]   Haidan Chen and Tikki Pang*, 2015, A Call for Global Governance of Biobanks, Bulletin of World Health Organization, 93, 113-117.

[8]   Haidan Chen*, 2014, BIONET: Herbert’s Road toward China, in Valediction for Herbert Gottweis, BioSocieties, 9(4), 475-477.

[9]   Johannes Starkbaum*, Haidan Chen and Herbert Gottweis, 2014, Publics and Biobanks in China and Europe: A Comparative Perspective. Asia Europe Journal, 12(3), 345-359.

[10]Haidan Chen*, 2013, Governing International Biobank Collaboration: A Case Study of China Kadoorie Biobank, Science, Technology and Society, 18(3), 321-338.

[11]Gregory Clancey* and Haidan Chen (special issue guest editors), 2013, Asian Biopoleis: Biomedical Research in ‘The Asian Century’, Science, Technology and Society, 18(3), 267-273.

[12]Haidan Chen*, Herbert Gottweis and Johannes Starkbaum, 2013, Public Perceptions of Biobanks in China: A Focus Group Study, Biopreservation and Biobanking, 11(5), 267-271.

[13]Haidan Chen and Herbert Gottweis*, 2013, Stem Cell Treatment in China: Rethinking the Patient Role in the Global Bio-Economy, Bioethics, 27(4), 194-207.

[14]Ayo Wahlberg*, Christoph Rehmann-Sutter, Margaret Sleeboom-Faulkner, Guangxiu Lu, Ole D？ring, Yali Cong, Alicja Laska-Formejster, Jing He, Haidan Chen, Herbert Gottweis and Nikolas Rose, 2013, From Global Bioethics to Ethical Governance of Biomedical Research Collaborations, Social Science and Medicine, 98, 293-300.

[15]Christian Haddad*, Haidan Chen and Herbert Gottweis, 2013, Unruly Objects: Novel Innovation Paths and Their Regulatory Challenge. In Andrew Webster (editor), The Global Dynamics of Regenerative Medicine: A Social Science Critique, Palgrave Macmillan, pp. 88-117.

[16]Herbert Gottweis*, Haidan Chen and Johannes Starkbaum, 2011, Biobanks and the Phantom Public, Human Genetics, 130(3), 433-440.

[17]Haidan Chen*, 2011, Cord Blood Banking in China: Public and Private Tensions, East Asian Science, Technology and Society: an International Journal, 5, 329-339.

[18]Haidan Chen*, 2009, Stem Cell Governance in China: From Bench to Bedside? New Genetics and Society, 28(3), 267-282.

Chinese Papers

[19]Haidan Chen*, 2019, Ethical Debates and the Governance of Science and Technology: A Case Study of Embryo and Stem Cell Research in the UK, Journal of Dialectics of Nature, 41(12), 40-46.

[20]Haidan Chen*, 2018, Review and Prospect of China’s Policies for Clinical Stem Cell Research, Journal of Dialectics of Nature, 40(3), 81-86.

[21]Haidan Chen*, 2013, Stem Cell Governance in China: From the Perspective of Co-production, Journal of Dialectics of Nature, 35(2), 112-117.

[22]Xiaoming Sheng* and Haidan Chen, 2007, Survey on Epistemic Culture through Laboratory Studies, Studies in Science of Science, 25(6), 1041-1046.

Research projects    

National projects

[1]   Ethical and Social Issues of Personalized Medicine (2015-2018), funded by the National Social Science Foundation of China, PI

[2]   Governance of Translational Medicine (2013-2016), funded by the Chinese Universities Scientific Fund, PI

[3]   Governance of Biobanks in China (2011-2013), funded by the Humanities and Social Sciences Research Programs of the Ministry of Education, PRC, PI

[4]   Biobank Governance (2010-2012), funded by the China Postdoctoral Science Foundation, PI

International projects

[5]   Regulation of International Direct-to-Participant Genomic Research (2018-2021), funded by the National Institutes of Health (NIH), collaborator

[6]   Biobanks in Developing Countries: Needs and Challenges for Global Governance (2014-2015), funded by the Lee Kuan Yew School of Public Policy, National University of Singapore, Co-PI with Tikki Pang

[7]   Harmonizing Privacy Laws to Enable International Biobank Research (2014-2016), funded by the National Institutes of Health (NIH), collaborator

[8]   Rising Powers II: State Strategies of Governance in Global Biomedical Innovation: The Impact of China and India (2012-2015), funded by the Economic and Social Research Council (ESRC), collaborator

[9]   Eco-Health Assessment on Poultry Production Clusters (PPCs) for the Livelihood Improvement of Small-scale Poultry Producers (2011-2014), funded by International Development Research Center (IDRC), collaborator

[10]Asian Biopoleis: Biotechnology & Biomedicine as Emergent Forms of Life & Practice, supported by the Singapore Ministry of Education and National University of Singapore (2010-2013), collaborator

[11]Rising Powers I: State Strategies of Governance in Global Biomedical Innovation: the Impact of China and India (2012-2015), funded by the Economic and Social Research Council (ESRC), collaborator

[12]Biomarker: Towards the Governance of an Emerging Medical Technology, funded by the Genome Program GEN-AU of the Austrian Federal Ministry of Science and Research (2009-2012), collaborator

[13]European Union 7th Research Framework project REMEDiE: Regenerative Medicine in Europe: Emerging Needs and Challenges in a Global Context (2008-2011), collaborator

[14]European Union 6th Research Framework project BIONET: Ethical Governance of Biological and Biomedical Research: Chinese and European Cooperation (2006-2009), junior research fellow